Future of In-Vitro Diagnostics Market (2026-2033) | Point-of-Care Testing, Molecular Diagnostics, Personalized Medicine | Key Players:- BioMerieux, Becton, Dickinson and Company

DataM Intelligence has released a new research report titled "In-Vitro Diagnostics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Humanoid & Embodied AI Robotics Market.

Download your executive sample report today (corporate email gets priority access):https://www.datamintelligence.com/download-sample/in-vitro-diagnostics-market?prtk

Market Size & Forecast:-

The Global In-Vitro Diagnostics market reached US$ 84.90 billion in 2024 and is expected to reach US$ 131.68 billion by 2032, growing at a CAGR of 5.0% during the forecast period 2025-2032.

The In-Vitro Diagnostics (IVD) market refers to medical devices, reagents, instruments, and systems used to test biological samples such as blood, urine, tissues, and other bodily fluids outside the human body to provide critical information for diagnosing, monitoring, and managing diseases and health conditions. These diagnostic tools include immunoassays, molecular diagnostics, clinical chemistry, hematology, and point-of-care testing platforms that help clinicians make timely and accurate healthcare decisions. The IVD market serves hospitals, diagnostic laboratories, clinics, and research institutions globally and is a foundational component of modern healthcare delivery.

The In-Vitro Diagnostics market is growing due to the rising prevalence of chronic and infectious diseases worldwide, which increases the demand for early detection, monitoring, and personalized treatment solutions. Technological advancements such as automated systems, molecular diagnostics, and portable point-of-care testing devices are enhancing test accuracy, speed, and accessibility, enabling faster clinical decisions and expanding diagnostics beyond traditional laboratory settings. Additionally, increasing healthcare spending, expansion of diagnostic infrastructure, and a global focus on preventive healthcare are driving sustained market growth.

Ready to scale in the In-Vitro Diagnostics Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/in-vitro-diagnostics-market?prtk

In-Vitro Diagnostics Market Recent development 2025-2026

United States

✅ February 2026: Roche Diagnostics launched an expanded cobas® liat Real-time PCR System for rapid, on-demand infectious disease testing in U.S. clinical settings, featuring AI-driven interpretation to shorten turnaround times and improve point-of-care diagnostics.

✅ January 2026: Beckman Coulter Diagnostics introduced RUO blood-based biomarker immunoassays for key neurodegenerative markers including p-Tau217, GFAP, NfL, and APOE ε4, aimed at accelerating Alzheimer's disease research in the U.S. market.

✅ November 2025: Abbott unveiled an upgraded Alinity m molecular diagnostics platform with expanded SARS-CoV-2/flu multiplex assays capable of 1,080 tests/hour, enhancing throughput for large hospital networks in the U.S.

Asia Pacific / Japan

✅ February 2026: Fujirebio Inc. (H.U. Group Holdings) released an updated LUMIPULSE® G system for plasma phosphorylated tau assays, advancing Alzheimer's biomarker research with PMDA-approved automation tailored for Japanese research institutes.

✅ December 2025: Sysmex Corporation announced the launch of the Innova QX8000 Dx NGS platform in Japan, enabling comprehensive genomic profiling from FFPE samples in under 24 hours for oncology diagnostics.

✅ October 2025: Toshiba (Canon Medical) debuted the V8 molecular diagnostics workstation in Japan, featuring fully automated TB/MDR-TB detection that reduces hands-on time by 70% for national TB control programs.

Strategic M&A(2025-2026)-

December 2025: Abbott Laboratories completed the acquisition of Exact Sciences for approximately USD 21 billion strengthening its diagnostics portfolio, particularly in cancer screening and precision diagnostics.

January 2025: bioMérieux agreed to acquire SpinChip Diagnostics (valued at NOK 1,624 million / EUR 138 million) to accelerate its point-of-care diagnostics platform and expand menu offerings.

Get customization in the report as per your requirements:https://www.datamintelligence.com/customize/in-vitro-diagnostics-market?prtk

Major Market Players:-
BioMerieux | Becton, Dickinson and Company | Beckman Coulter, Inc | F. Hoffmann-La Roche Ltd. | Bio-Rad Laboratories, Inc | Abbott Laboratories | Qiagen NV | FUJIFILM Holdings Corporation | Sysmex Corporation | Siemens Healthineers AG

In-Vitro Diagnostics Market Market Segmentation Analysis-

By Product Type (Instruments, Reagents, Software and Services, Others),

By Technique Type (Immunoassays, POC Diagnostics, Molecular Diagnostics, Hematology, Tissue Diagnostics, Microbiology, Self-Blood-Glucose Monitoring, Others),

By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing, Others),

By End-User (Diagnostic Laboratories, Hospitals, Academics and Research Institutes, Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Growth Forecast Projected 2033:

The Global In-Vitro Diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

How Our Market Research Process Works:

The global In-Vitro Diagnostics Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Low-Power Wide-Area Network ecosystem.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

📈 Secure your 30% discount on the full report: https://www.datamintelligence.com/buy-now-page?report=in-vitro-diagnostics-market?prtk

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.